-
OraSure Secures $13.6M BARDA Funding For InteliSwab COVID-19 Test 510(k) Clearance and CLIA Waiver
Thursday, September 23, 2021 - 10:00am | 299Read More...The Biomedical Advanced Research Development Authority (BARDA) will provide up to $13.6 million in funding to OraSure Technologies Inc (NASDAQ: OSUR). The fund is related to obtain 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for OraSure's...
-
OraSure Secures $205M Contract For OTC COVID-19 Tests
Monday, September 20, 2021 - 6:54am | 281Read More...The Defense Logistics Agency has awarded OraSure Technologies Inc (NASDAQ: OSUR) a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use. Related Link: OraSure Stock Is Trading Lower As Q2 Earnings, Outlook Trail Estimates. The estimated value of...
-
FDA Warns On Potential False Positive Results With Abbott's COVID-19 Lab Tests
Friday, September 17, 2021 - 1:51pm | 386Read More...The FDA has issued a letter to healthcare professionals alerting them to the potential for false-positive results with Abbott Laboratories (NYSE: ABT) two COVID-19 diagnostic tests. Related Link: Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT. The alert relates to...
-
Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M
Tuesday, September 14, 2021 - 1:02pm | 259Read More...Mesa Laboratories Inc (NASDAQ: MLAB) has agreed to acquire Agena Bioscience Inc for a cash purchase price of $300 million. The San Diego, California-based Agena offers genetic analysis solutions to clinical labs and development partners. Excluding the impact of COVID-19 related...
-
FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label
Tuesday, September 14, 2021 - 7:40am | 268Read More...The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The expanded label will include testing with a nasal swab and saliva samples and asymptomatic serial testing with nasal swab...
-
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
Monday, September 13, 2021 - 2:56pm | 376Read More...Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear. The Galleri test checks for the earliest signs of cancer in the...
-
T2 Biosystems' Stock Jumps As Its COVID-19 Molecular Test Can Detect Mu, Iota Variants
Friday, September 10, 2021 - 6:47am | 278Read More...T2 Biosystems Inc (NASDAQ: TTOO) announced that its T2SARS-CoV-2 Panel is capable of detecting the Mu (B.1.621) and Iota (B.1.526) variants, which were recently confirmed to be present in the U.S. Also Read: T2 Biosystems Q2 Earnings Edges Wall Street Estimates On Higher Test...
-
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
Thursday, September 9, 2021 - 9:55am | 321Read More...Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the end of August. Related Content: Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues...
-
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
Thursday, September 9, 2021 - 7:09am | 167Read More...Roche Holdings AG (OTC: RHHBY) has agreed to acquire TIB Molbiol Group for an undisclosed amount. The deal is expected to close in Q4 of 2021. The acquisition will enhance Roche's portfolio of molecular diagnostics solutions with a wide range of assays for infectious...
-
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
Tuesday, September 7, 2021 - 10:38am | 274Read More...Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge genetic mutations involved in homologous recombination deficiency (HRD) and identify best responders to PARP inhibitors....
-
Labcorp Increases Minimum Hourly Wage To $15
Friday, September 3, 2021 - 7:18am | 316Read More...Laboratory Corp of America Holdings (NYSE: LH) has increased the minimum hourly wage for U.S.-based employees to $15 from $10.95. The Company joins several other firms in implementing measures to retain staff amid a nationwide labor shortage. Lab Corp has more than 70,000 employees and...
-
Thermo Fisher Receives $192.5M Contract From US Govt For Pipette Tip Manufacturing
Thursday, September 2, 2021 - 1:14pm | 202Read More...Thermo Fisher Scientific Inc (NYSE: TMO) has announced a $192.5 million contract award from the U.S. Department of Defense (DoD). The contract covers the domestic production of pipette tips used within research and diagnostic labs to dispense precise amounts of liquid. In mid-...
-
Baxter to Acquire Hillrom At $156/Share: See The Highlights
Thursday, September 2, 2021 - 8:41am | 397Read More...Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier anticipated $150. Related Content: Baxter In Advanced Talks For $10B Hill Rom Buyout The deal values HRC's...
-
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
Thursday, September 2, 2021 - 8:19am | 297Read More...Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across the U.S. and online at cvs.com. CVS Pharmacy is a part of CVS Health Corp (NYSE: CVS). Related Content: ...
-
Meridian Bioscience Expands Voluntary Recall of LeadCare Test Kits
Thursday, September 2, 2021 - 7:58am | 281Read More...Meridian Bioscience Inc's (NASDAQ: VIVO) subsidiary Magellan Diagnostics Inc has expanded the Class I recall of its LeadCare Test Kits used to detect lead in whole blood. Magellan provides two controls in the test kits designed to mimic blood and are spiked with lead...
















